Trials / Conditions / Congenital Myotonic Dystrophy
Congenital Myotonic Dystrophy
8 registered clinical trials studyying Congenital Myotonic Dystrophy — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension NCT06747884 | Virginia Commonwealth University | — |
| Recruiting | DMCRN-02-001: Assessing Pediatric Endpoints in DM1 NCT05224778 | Virginia Commonwealth University | — |
| Recruiting | Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy NCT05004129 | AMO Pharma Limited | Phase 2 / Phase 3 |
| Completed | Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy NCT03692312 | AMO Pharma Limited | Phase 2 / Phase 3 |
| Completed | Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy NCT03059264 | Virginia Commonwealth University | — |
| Recruiting | Myotonic Dystrophy Family Registry NCT02398786 | Myotonic Dystrophy Foundation | — |
| Recruiting | Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry NCT00082108 | University of Rochester | — |
| Available | Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy NCT07119775 | AMO Pharma Limited | — |